Ionis Pharmaceuticals, Inc.

IONS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$242,077$399,266$276,472$869,191
Short-Term Investments$2,055,579$1,931,935$1,720,936$1,263,987
Receivables$92,188$97,778$25,538$61,896
Inventory$12,512$7,441$22,033$24,806
Other Curr. Assets$217,934$205,433$157,715$125,169
Total Curr. Assets$2,620,290$2,641,853$2,202,694$2,345,049
Property Plant & Equip (Net)$256,107$242,939$255,838$196,043
Goodwill$0$0$0$0
Intangibles$0$0$0$29,005
Long-Term Investments$41,023$42,991$40,372$32,322
Tax Assets$0$0$0$0
Other NC Assets$86,255$62,289$34,972$9,271
Total NC Assets$383,385$348,219$331,182$266,641
Other Assets$0$0$0$0
Total Assets$3,003,675$2,990,072$2,533,876$2,611,690
Liabilities
Payables$42,964$26,027$17,921$11,904
Short-Term Debt$9,279$53,163$7,535$3,526
Tax Payable$34$2,151$6,249$36
Deferred Revenue$78,989$151,128$90,577$97,714
Other Curr. Liab.$178,052$215,621$189,279$127,370
Total Curr. Liab.$309,318$448,090$311,561$240,550
LT Debt$1,407,290$1,400,376$1,361,660$1,247,524
Deferred Rev, NC$156,504$241,184$287,768$351,879
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$542,212$513,736$287,768$0
Total NC Liab.$2,106,006$2,155,296$1,649,428$1,599,403
Other Liabilities$0$0$0$0
Cap. Leases$161,805$170,875$178,941$19,432
Total Liabilities$2,415,324$2,603,386$1,960,989$1,839,953
Equity
Pref Stock$0$0$0$0
Common Stock$158$144$142$141
Retained Earnings-$2,249,808-$1,795,911-$1,429,625-$1,159,903
AOCI-$30,811-$32,645-$57,480-$32,668
Other Equity$2,868,812$2,215,098$2,059,850$1,964,167
Total Equity$588,351$386,686$572,887$771,737
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$3,003,675$2,990,072$2,533,876$2,611,690
Net Debt$1,174,492$1,054,273$1,092,723$381,859